Log In
Sunday 25th August 2019

Thyroid drug will remain available on the NHS

1st December 2017

Health bosses reconsidered proposal to restrict access to the thyroid drug, liothyronine.

Click on available sources in right hand menu to see the original article.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2019